Saiid Zarrabian

Saiid Zarrabian

Company: Kintara Therapeutics

Job title: President & Chief Executive Officer

Seminars:

Role of Cytotoxic Agents in GBM 2:30 pm

GBM Treatment Challenges History of VAL-083 Unique Mechanism of Action of VAL-083 VAL-083 Treatment Arm in the GCAR GBM AGILE StudyRead more

day: Day One

© Copyright 2018 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Suite A, 6 Honduras Street, London EC1Y 0TH.